Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples